Abarelix
Top View
- WO 2016/040896 Al FIG. JO
- Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors
- Response to ICER's Draft Scoping Document Regarding Elagolix for Endometriosis Abbvie Appreciates the Opportunity to Provide C
- Incidence of Skeletal-Related Events in Men with Castration-Resistant Prostate Cancer
- Medical Review(S)
- Triptorelin Relieves Lower Urinary Tract Symptoms in Chinese Advanced Prostate Cancer Patients
- Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer
- 2082 Sex Hormones and Their Modulators
- Regulation of Testicular Function in Men: Implications for Male Hormonal Contraceptive Developmentଝ John K
- Separated from the Host, and Nits Hatch in 7–10 Days, Careful Sealing of Fomites in Plastic Bags for 2 Weeks Can Also Be Effec
- Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
- Plenaxis™ (Abarelix for Injectable Suspension)
- Gonadotropin-Releasing Hormone Antagonists Karen L Herbst
- Gnrh Antagonists
- ODS Customary Specialty Medication Review Criteria Effective 10/01/2008
- WO 2010/032200 Al
- Gnrh Receptor Gonadotropin Releasing Hormone Receptor; GNRHR
- Gonadotropin-Releasing Hormone and Its Receptor in Normal and Malignant Cells